Oncobiologics, Inc. (OTLK)

Last Closing Price: 0.33 (2026-05-21)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Oncobiologics, Inc. (OTLK) had Net Income of $-4.45M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$0.13M
Net Income
$-4.45M
$0.15M
$-0.02M
$14.15M
$-14.03M
$9.57M
$-4.45M
$-4.45M
$-4.45M
$-4.45M
$-4.45M
$-4.45M
$-14.03M
$-14.00M
81.84M
81.84M
$-0.05
$-0.05
Balance Sheet Financials
$20.90M
--
$0.99M
$21.89M
$38.88M
$11.12M
$12.00M
$50.89M
$-28.99M
$-28.99M
$-28.99M
104.61M
Cash Flow Statement Financials
$-22.77M
--
$22.43M
$8.08M
$7.75M
$-0.33M
$1.64M
--
--
Fundamental Metrics & Ratios
0.54
--
--
-0.62
-0.93
-17.18%
-11006.82%
-11006.82%
--
-3494.28%
-3494.28%
$-22.77M
--
--
--
0.01
0.04
0.05
1920.80
15.36%
15.36%
-20.34%
24.92%
$-0.28
$-0.28
$-0.28